Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Clinical trial NCT01395017 · COMPLETED
Trial details
- NCT number
- NCT01395017
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2013-10-01
- Enrollment
- 202
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.